ANDA 207547, held by Amneal. Levoleucovorin Calcium.
As of Nov 16, 2026, ANDA 207547 (Levoleucovorin Calcium), held by Amneal, was first approved by FDA on Feb 13, 2017, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 13, 2017 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Levoleucovorin CalciumEQ 50MG BASE/VIAL · powder;intravenous | Levoleucovorin Calcium | Discontinued |
| Dec 14, 2022 | Supplement 1Labeling · Standard review | Approved | None posted |
| Dec 14, 2022 | Supplement 7Labeling · Standard review | Approved | None posted |
| Feb 13, 2017 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters